Anticancer agent 284
Anticancer agent 284 exhibits cytotoxicity against osteosarcoma cell line (Hos), non-small cell lung cancer cell line (A549), and colon cancer cell line (HCT-116). Anticancer agent 284 can impact the pRIPK3 kinase concentration in the A549 (2.97 pg/mL). Anticancer agent 284 can be used for the study of cancer.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- 화학식: C26H25N5O3S
- 분자량:487.57
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Anticancer agent 284 (Compound 4) cytotoxic against all the tested cell lines, with an IC50 activity order of HCT-116 (7.3 µM) > A549 (20.4 µM) > Hos (39.9 µM)[1].
Anticancer agent 284 slightly inhibis pRIPK3 in A549 cells (2.97 pg/mL)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:A549 human lung cancer cells
-
Concentration:20.4 μM (treat with the IC50 concentration of the active compound)
-
Incubation Time:24 h
-
Result:Impacted the pRIPK3 kinase concentration in the A549 (2.97 pg/mL).
Chemical Information
-
분자량 487.57
-
화학식 C26H25N5O3S
-
SMILES
CC1=CC=C(C=C1)S(=O)(N/N=C(C2=CC=C(C=C2)N/C=C3C(N(N=C/3C)C4=CC=CC=C4)=O)\C)=O
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)